EWTX Smart Money
Edgewise Therapeutics, Inc.
1W: -0.6%
1M: -0.7%
3M: -0.6%
YTD: +66.4%
1Y: +160.4%
3Y: +478.8%
5Y: +143.3%
$39.53
+0.36 (+0.92%)
Pre-Market: $40.25 (+0.72, +1.82%)
Weekly Expected Move ±5.6%
$35
$37
$39
$41
$44
Credit Risk of going bust: lower than 83% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Edgewise Therapeutics, Inc. would be worth roughly what it owes.
Total debt $3.6M against a stock market value of $4.25B.
Distance to default 10.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 72.0%; Altman Z'' 13.74. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Edgewise Therapeutics, Inc. would be worth roughly what it owes.
Total debt $3.6M against a stock market value of $4.25B.
Distance to default 10.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 72.0%; Altman Z'' 13.74. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026258
Institutions Holding
+20 vs prior
113.1%
Ownership
+25.76%
46
New
82
Increased
100
Reduced
27
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Fox Jonathan C | director | A-Grant/Award | 308 | $— | $0 | Filing |
| 2026-08-13 | Donovan Joanne M. | officer: cmo | S-Sale | 2,919 | $43.41 | $127K | Filing |
| 2026-08-12 | Donovan Joanne M. | officer: cmo | S-Sale | 104 | $44.43 | $5K | Filing |
| 2026-08-12 | KOCH KEVIN | officer: president and ceo | S-Sale | 8,782 | $43.64 | $383K | Filing |
| 2026-08-12 | KOCH KEVIN | officer: president and ceo | S-Sale | 8,276 | $43.66 | $361K | Filing |
| 2026-08-12 | KOCH KEVIN | officer: president and ceo | S-Sale | 913 | $44.33 | $40K | Filing |
| 2026-08-12 | MOORE JOHN R | officer: general counsel | S-Sale | 2,439 | $43.81 | $107K | Filing |
| 2026-08-12 | MOORE JOHN R | officer: general counsel | S-Sale | 59 | $44.41 | $3K | Filing |
| 2026-08-12 | MOORE JOHN R | officer: general counsel | S-Sale | 99 | $44.50 | $4K | Filing |
| 2026-08-12 | MOORE JOHN R | officer: general counsel | S-Sale | 2,419 | $43.80 | $106K | Filing |
| 2026-08-12 | Donovan Joanne M. | officer: cmo | S-Sale | 2,839 | $43.78 | $124K | Filing |
| 2026-08-12 | Donovan Joanne M. | officer: cmo | S-Sale | 2,779 | $43.71 | $121K | Filing |
| 2026-08-12 | Donovan Joanne M. | officer: cmo | S-Sale | 800 | $44.52 | $36K | Filing |
| 2026-08-12 | Derakhshan Behrad | officer: chief business officer | S-Sale | 2,171 | $43.79 | $95K | Filing |
| 2026-08-12 | Derakhshan Behrad | officer: chief business officer | S-Sale | 304 | $44.50 | $14K | Filing |
| 2026-08-12 | Derakhshan Behrad | officer: chief business officer | S-Sale | 150 | $44.44 | $7K | Filing |
| 2026-08-12 | Derakhshan Behrad | officer: chief business officer | S-Sale | 2,475 | $43.70 | $108K | Filing |
| 2026-08-12 | Russell Alan J | officer: chief scientific officer | S-Sale | 3,238 | $43.68 | $141K | Filing |
| 2026-08-12 | Russell Alan J | officer: chief scientific officer | S-Sale | 2,273 | $43.68 | $99K | Filing |
| 2026-08-12 | Russell Alan J | officer: chief scientific officer | S-Sale | 390 | $44.46 | $17K | Filing |
| 2026-07-01 | Fox Jonathan C | director | A-Grant/Award | 319 | $— | $0 | Filing |
| 2026-07-01 | Russell Alan J | officer: chief scientific officer | S-Sale | 130,352 | $39.41 | $5.1M | Filing |
| 2026-07-01 | Russell Alan J | officer: chief scientific officer | S-Sale | 69,648 | $39.41 | $2.7M | Filing |
| 2026-05-05 | Donovan Joanne M. | officer: cmo | S-Sale | 50,000 | $38.57 | $1.9M | Filing |
| 2026-05-04 | Donovan Joanne M. | officer: cmo | S-Sale | 5,230 | $31.29 | $164K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 15,518,492 | $631M | — | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 10,215,455 | $415M | +2,850,417 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 8,392,730 | $341M | -2,035,707 | 2026-06-30 | Filing |
| BlackRock, Inc. | 6,606,336 | $268M | +133,345 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 6,075,331 | $247M | +6,075,331 | 2026-06-30 | Filing |
| FMR LLC | 5,489,135 | $223M | +4,472,083 | 2026-06-30 | Filing |
| NOVO HOLDINGS A/S | 5,350,000 | $217M | — | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 4,728,623 | $192M | +250,681 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 4,373,974 | $178M | -50,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,860,670 | $157M | +72,509 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 3,701,719 | $150M | -2,874,221 | 2026-06-30 | Filing |
| Siren, L.L.C. | 3,184,629 | $129M | -1,245,634 | 2026-06-30 | Filing |
| Cormorant Asset Management, LP | 2,510,000 | $102M | -750,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,174,051 | $88M | +384,232 | 2026-06-30 | Filing |
| Integral Health Asset Management, LLC | 2,000,000 | $81M | +400,000 | 2026-06-30 | Filing |
| BRAIDWELL LP | 1,996,965 | $81M | -350,618 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,948,597 | $79M | -297,431 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,827,927 | $74M | +111,104 | 2026-06-30 | Filing |
| ALLIANCEBERNSTEIN L.P. | 2,119,024 | $67M | +396,855 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 1,620,780 | $66M | -39,916 | 2026-06-30 | Filing |